Examkin

Question

Difficulty: HardImmunologic and Inflammatory Processes

During a scheduled evaluation at the transplant hepatology clinic, a 51-year-old male who received an orthotopic liver transplant 7 weeks ago reports new-onset fatigue, dark urine, and mild right-sided abdominal aching. His immunosuppressive regimen consists of tacrolimus, mycophenolate mofetil, and low-dose prednisone. Vital signs are stable, and physical examination reveals mild scleral icterus. Laboratory evaluation demonstrates an alanine aminotransferase (ALT) of 450 U/L, aspartate aminotransferase (AST) of 380 U/L, total bilirubin of 3.8 mg/dL, and an alkaline phosphatase of 210 U/L. Serum tacrolimus trough levels are strictly within the therapeutic range. The physician strongly suspects acute cellular rejection. Arrange the following diagnostic and management steps in the most appropriate clinical sequence.

  1. 1Perform a right upper quadrant abdominal Doppler ultrasound
  2. 2Obtain a percutaneous liver allograft biopsy
  3. 3Administer pulse-dose intravenous methylprednisolone
  4. 4Initiate treatment with anti-thymocyte globulin

Answer

The correct sequence begins with ruling out vascular and biliary complications via Doppler ultrasound, followed by a liver biopsy to confirm the immunologic diagnosis, then first-line therapy with pulse-dose steroids, and finally anti-thymocyte globulin if the rejection proves steroid-refractory.
The precise chronological order for evaluating acute graft dysfunction relies on prioritizing life-threatening surgical complications first, confirming the immunologic pathology second, and administering escalating tiers of targeted immunosuppression third and fourth. Therefore, Doppler ultrasound precedes biopsy, which precedes corticosteroids, which precedes anti-thymocyte globulin.

Step-by-Step Solution

1
Rule out mechanical and vascular complications.
Right upper quadrant abdominal Doppler ultrasound is performed.
Hepatic artery thrombosis or biliary strictures can perfectly mimic acute rejection but require immediate surgical or endoscopic intervention rather than immunosuppression.
2
Confirm the immunologic diagnosis histologically.
Percutaneous liver allograft biopsy is obtained.
Biopsy distinguishes acute cellular rejection from other causes of graft dysfunction such as cytomegalovirus hepatitis or recurrent primary disease, ensuring immunosuppressants are not inappropriately increased during an active infection.
3
Initiate primary immunologic therapy for acute rejection.
Pulse-dose intravenous methylprednisolone is administered.
Once acute cellular rejection is histologically confirmed, high-dose corticosteroids are the most rapid and effective first-line treatment to suppress the inflammatory response.
4
Escalate immunosuppressive therapy if the patient fails to respond.
Anti-thymocyte globulin is initiated.
If the cellular rejection is steroid-resistant or presents with severe necrosis on follow-up histology, powerful T-cell depleting agents are utilized as salvage therapy.

Key Concept

The management of suspected acute cellular rejection in solid organ transplantation follows a strict sequence: exclude mechanical/vascular etiologies, confirm the diagnosis histologically, initiate first-line high-dose corticosteroids, and reserve lymphocyte-depleting agents for steroid-refractory cases.
Rate this question

Topics

Immunologic and Inflammatory Processes

More questions from this topic